Selinexor Gains FDA Fast Track Designation for Refractory Multiple Myeloma Patients
Selinexor, the lead oral therapy developed by Karyopharm Therapeutics, received …
News
China FDA Prepares to Review Evomela for Approval in Multiple Myeloma Treatment
Multiple myeloma patients in China may soon have access to an injectable formulation of melphalan, called Evomela, as the China Food and Drug…
Multiple Myeloma Research Foundation Awards $7 Million to Accelerate Precision Immunotherapies for Myeloma Patients
As part of its $15 million Immunotherapy Initiative, the Multiple Myeloma Research Foundation (MMRF) recently awarded $7 million in funding to three innovative research…
Xgeva Gains Europe’s Approval for Preventing Bone Lesions in Multiple Myeloma
The European Commission has extended Xgeva‘s (denosumab) approval for the prevention of bone lesions in multiple myeloma patients, Amgen, the medicine’s maker, announced. The…
Revlimid, Dexamethasone Combo Shows Benefits for Multiple Myeloma in Real-world Study
The combination of Revlimid (lenalidomide) and dexamethasone for the treatment of relapsed or refractory multiple myeloma showed similar benefits in routine clinical practice as it did…
Bluebird Bio and Celgene Partner to Advance bb2121, Potential Multiple Myeloma CAR T-cell Therapy
The investigational therapy bb2121, a possible treatment for relapsed or refractory multiple myeloma patients, is advancing in clinical testing under a recently announced partnership…
ACCoRd Trial to Test Ninlaro Treatment for ASCT-Relapsed Multiple Myeloma
A new Phase 3 clinical trial called ACCoRd is underway to investigate the benefits of adding Ninlaro (ixazomib) – a proteasome inhibitor – to…
AbbVie, IMF Team Up to Study Gene Mutation in Myeloma Outcomes
AbbVie and the International Myeloma Foundation are collaborating to study the role of a genetic mutation — the t(11;14) translocation — in multiple myeloma treatments…
SELLAS Vaccine More Than Doubles Time to Myeloma Progression, Phase 2 Trial Shows
SELLAS Life Sciences’  Galinpepimut-S vaccine more than doubles the time it takes for high-risk multiple myeloma patients’ cancer to worsen, a Phase 2 clinical trial shows.
Medicinal Cannabis Safe and Effective for Pain, Chemo Side Effects, Journal Says
The supervised use of medicinal cannabis is safe and effective at relieving pain and reducing chemotherapy-induced nausea and vomiting in cancer patients, an increasing body of…
